Join us on April 15, 2020 at 10am Pacific / 1pm Eastern / 7pm Central Europe to learn about the associated cancer risks from exposure to arsenic, glyphosate, and other endocrine disrupting chemicals (EDCs).
There is a growing body of scientific literature linking certain types of cancers to endocrine disrupting chemicals (EDCs) in consumer products, pesticides, as well as heavy metals present in the environment. Dr. Gail Prins will open the webinar giving an overview of EDCs and cancer risk. She will also present evidence, which documents that early life exposure to BPA (and other environmental agents) increases prostate cancer susceptibility to hormonal carcinogenesis with aging. Dr. Prins will present data showing that the prostate stem and progenitor cell population are direct targets and that this is sufficient to enhance prostate cancer risk in both rodent and human prostate models.
Dr. Lianne Sheppard will then present an updated meta-analysis for the association of glyphosate with non-Hodgkin lymphoma (NHL). Considerable controversy surrounds the pesticide glyphosate, a non-selective systemic herbicide commonly sold as Roundup®. In order to investigate whether glyphosate is a human carcinogen, Dr. Sheppard and colleagues focused on the most highly exposed workers in the selected studies. The results from this meta-analysis suggest a compelling link between glyphosate exposure and NHL.
To close the webinar, Dr. Taehyun Roh will give a talk on the risks of lung, bladder, and kidney cancer associated with arsenic exposure. Arsenic is naturally present at high levels in the groundwater of many countries, posing a threat to public health. During this talk, Dr. Roh will discuss research from his study investigating long latency patterns 40 years after high arsenic exposure reduction and increased incidence of lung, bladder, and kidney cancers.
For full details, visit https://www.healthandenvironment.org and select this webinar at the bottom of the homepage.